Reference range for C1-esterase inhibitor (C1 INH) in the third trimester of pregnancy.

This study successfully demonstrated that a reference value for C1 INH activity can be established using the methods described herein. Further research is needed to determine whether C1 INH is involved in obstetric coagulopathy syndrome such as amniotic fluid embolism.